CJ
Corinne Jenkins Goldman Sachs Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Geron
GERN
$893M
| $1.40 | $1 |
29%
downside
| Sell | 1 month ago |
|
2 |
2
Rhythm Pharmaceuticals
RYTM
$6.78B
| $102.12 | $66 |
35%
downside
| Buy | 9 months ago |
|
3 |
3
TG Therapeutics
TGTX
$5.11B
| $32.21 | $22 |
32%
downside
| Neutral | 10 months ago |
|
4 |
4
Fulcrum Therapeutics
FULC
$414M
| $7.66 | $15 |
96%
upside
| Buy | 1 year ago |
|
5 |
5
IDEAYA Biosciences
IDYA
$2.38B
| $27.16 | $46 |
69%
upside
| Buy | 1 year ago |
|
6 |
6
Roivant Sciences
ROIV
$8.82B
| $12.92 | $18 |
39%
upside
| Buy | 1 year ago |
|
7 |
7
Altimmune
ALT
$334M
| $3.78 | $13 |
244%
upside
| Neutral | 1 year ago |
|
8 |
8
Harmony Biosciences
HRMY
$2.07B
| $35.99 | $28 |
22%
downside
| Sell | 1 year ago |
|
9 |
9
Terns Pharmaceuticals
TERN
$632M
| $7.22 | $14 |
94%
upside
| Buy | 2 years ago |
|